Stockscreener 앱 받기
10.84
4.69%
0.485
시간 외 거래:
10.50
-0.335
-3.09%
전일 마감가:
$10.35
열려 있는:
$10.38
하루 거래량:
117.53K
Relative Volume:
0.09
시가총액:
$86.20M
수익:
$49.09M
순이익/손실:
$-52.15M
주가수익비율:
-16.67
EPS:
-0.65
순현금흐름:
$-45.93M
1주 성능:
+8.79%
1개월 성능:
+34.10%
6개월 성능:
+31.81%
1년 성능:
-42.37%
1일 변동 폭
$9.83
$11.00
1주일 범위
$9.8101
$11.00
52주 변동 폭
$3.436
$20.40
바이오데식스 Stock (BDSX) Company Profile
명칭
Biodesix Inc
전화
303-417-0500
주소
919 WEST DILLON ROAD, LOUISVILLE
Compare BDSX vs TMO, DHR, IDXX, A, WAT
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BDSX
Biodesix Inc
|
10.84 | 82.34M | 49.09M | -52.15M | -45.93M | -0.65 |
|
TMO
Thermo Fisher Scientific Inc
|
509.82 | 198.06B | 44.56B | 6.73B | 6.29B | 17.74 |
|
DHR
Danaher Corp
|
214.94 | 155.50B | 24.57B | 3.60B | 5.25B | 5.0475 |
|
IDXX
Idexx Laboratories Inc
|
617.20 | 51.80B | 4.30B | 1.06B | 1.04B | 13.08 |
|
A
Agilent Technologies Inc
|
124.88 | 36.46B | 6.95B | 1.30B | 1.15B | 4.5696 |
|
WAT
Waters Corp
|
319.83 | 32.29B | 3.17B | 642.63M | 539.81M | 10.77 |
바이오데식스 Stock (BDSX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-05-14 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2024-09-16 | 개시 | Scotiabank | Sector Outperform |
| 2024-07-26 | 개시 | Craig Hallum | Buy |
| 2024-05-13 | 개시 | TD Cowen | Buy |
| 2024-05-03 | 개시 | Lake Street | Buy |
| 2021-11-17 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2020-11-23 | 개시 | BTIG Research | Buy |
| 2020-11-23 | 개시 | Canaccord Genuity | Buy |
| 2020-11-23 | 개시 | Morgan Stanley | Overweight |
| 2020-11-23 | 개시 | William Blair | Outperform |
모두보기
바이오데식스 주식(BDSX)의 최신 뉴스
Short Interest in Biodesix, Inc. (NASDAQ:BDSX) Declines By 48.4% - MarketBeat
Biodesix, Inc. Announces Fourth Quarter and Full Year 2025 Financial Results Release Date and Conference Call Details - Quiver Quantitative
Biodesix to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026 - The Manila Times
Biodesix (NASDAQ:BDSX) CEO Scott Hutton Sells 3,559 Shares - MarketBeat
What is Biodesix Inc. s 5 year growth outlookQuarterly Investment Review & AI Based Buy and Sell Signals - mfd.ru
Biodesix, Inc. (NASDAQ:BDSX) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
Biodesix, Inc. (NASDAQ:BDSX) Receives Average Rating of “Moderate Buy” from Brokerages - Defense World
Can Biodesix Sustain Its Growth Momentum In 2026? - RTTNews
Telemark Asset Management, LLC Increases Stake in Biodesix Inc - GuruFocus
What is the dividend yield of Biodesix IncWeekly Investment Report & AI Forecast for Swing Trade Picks - baoquankhu1.vn
Biodesix (NASDAQ:BDSX) Director Jack Schuler Purchases 82,465 Shares - Defense World
Short Interest in Biodesix, Inc. (NASDAQ:BDSX) Increases By 499.1% - MarketBeat
Hedge Fund and Insider Trading News: Seth Klarman, Dan Loeb, Michael Burry, Michael Platt, Bridgewater Associates, Greenlight Capital, Biodesix Inc (BDSX), UWM Holdings Corp (UWMC), and More - Insider Monkey
Biodesix (NASDAQ:BDSX) Director Jack Schuler Purchases 80,000 Shares - MarketBeat
Biodesix (NASDAQ:BDSX) Director Acquires $236,000.00 in Stock - MarketBeat
Biodesix director Schuler buys $1.1m+ in BDSX stock By Investing.com - Investing.com South Africa
Biodesix director Schuler buys $1.1m+ in BDSX stock - Investing.com
Biodesix (NASDAQ:BDSX) Director Jack Schuler Buys 82,465 Shares - MarketBeat
Biodesix (BDSX) emeritus director Schuler buys $903k in stock By Investing.com - Investing.com Nigeria
Biodesix (BDSX) emeritus director Schuler buys $903k in stock - Investing.com
Perkins Capital Management Inc. Has $397,000 Position in Biodesix, Inc. $BDSX - MarketBeat
Big Money Moves: Can Biodesix Inc expand into new marketsTrade Risk Summary & Entry Point Confirmation Signals - baoquankhu1.vn
Reviewing Biodesix (NASDAQ:BDSX) and HealthEquity (NASDAQ:HQY) - Defense World
How geopolitical tensions affect Biodesix Inc. stockWeekly Trade Review & High Accuracy Investment Entry Signals - bollywoodhelpline.com
BDSX stock shot up 23% pre-market today — what’s fueling the surge? - MSN
Biodesix Inc. (BDSX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Biodesix, Inc. (NASDAQ:BDSX) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
Investors Still Aren't Entirely Convinced By Biodesix, Inc.'s (NASDAQ:BDSX) Revenues Despite 26% Price Jump - Sahm
Biodesix stock soars as preliminary results exceed guidance, achieves EBITDA profitability - Investing.com Nigeria
Quarterly Trades: Will Biodesix Inc stock rally after Fed decisions2025 Market Overview & Growth Focused Entry Point Reports - Bộ Nội Vụ
Biodesix: Strengthening Fundamentals, Emerging Profitability, and Strategic Growth Support Buy Rating and $20 Price Target - TipRanks
Biodesix, Inc. at Risk: How a Federal Shutdown Could Disrupt Revenue and Growth - MSN
Biodesix: Strong Operational Momentum but Ongoing Capital Concerns Justify Hold Rating - TipRanks
Biodesix reports 41% revenue growth in Q4, exceeds 2025 guidance By Investing.com - Investing.com Nigeria
Biodesix sees stock soar after surpassing sales guidance - BizWest
BDSX Faces Financial Hurdles as Stock Volatility Heightens - StocksToTrade
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
Biodesix Shares Rocket 42% on Record FY2025 Results and Path to Profitability - FinancialContent
BDSX Stock Shot Up 23% Pre-Market Today — What’s Fueling The Surge? - Asianet Newsable
Biodesix Stock Rebounds on Strategic Plans for Market Expansion - timothysykes.com
This Diagnostics Stock Is Surging 23% Pre-Market Today – Here’s Why - Stocktwits
Biodesix (BDSX) Surges 41% on Strong Preliminary Q4 and FY Resul - GuruFocus
Biodesix Surges On Strong Preliminary Q4 And FY2025 Revenue Results - Nasdaq
바이오데식스 (BDSX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.18%
자본화:
|
볼륨(24시간):